Depression and Anxiety Reduction Treatment for Suicide
| Status: | Completed |
|---|---|
| Conditions: | Anxiety, Depression, Depression, Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 6/21/2018 |
| Start Date: | November 2013 |
| End Date: | September 2017 |
Development and Evaluation of a Brief, Suicide Prevention Intervention Targeting Anxiety and Mood Vulnerabilities
The purpose of this study is to test the effectiveness and usability of multiple
computer-based treatments for mood and anxiety relevant risk factors. The target of the
treatment is related to cognitive stress, which has been shown to be associated with a
variety of negative mental health outcomes such as Post-Traumatic Stress Disorder, suicidal
ideation, and substance use disorders.
computer-based treatments for mood and anxiety relevant risk factors. The target of the
treatment is related to cognitive stress, which has been shown to be associated with a
variety of negative mental health outcomes such as Post-Traumatic Stress Disorder, suicidal
ideation, and substance use disorders.
DARTS is a newly developed computerized treatment targeting specific risk factors associated
with suicide, mood, and anxiety symptoms. Eligible individuals will be randomized to one of
several conditions. In all conditions, participants will complete various self-report
questionnaires and a neurophysiology assessment that involves an EEG. Some participants will
also be asked to complete four additional EEG assessments. In addition, all participants will
be asked to complete a 1, 3, and 6-month follow-up appointment.
with suicide, mood, and anxiety symptoms. Eligible individuals will be randomized to one of
several conditions. In all conditions, participants will complete various self-report
questionnaires and a neurophysiology assessment that involves an EEG. Some participants will
also be asked to complete four additional EEG assessments. In addition, all participants will
be asked to complete a 1, 3, and 6-month follow-up appointment.
Inclusion Criteria:
- At or above community sample mean on ASI-3
- At or above community sample mean on INQ-R
- English speakers
- 18 years of age or older
Exclusion Criteria:
- Significant medical illness
- Current substance dependence
- Current or past psychotic-spectrum disorders
- Uncontrolled bipolar disorder
- Serious suicidal intent that warranted immediate treatment
We found this trial at
1
site
Tallahassee, Florida 32306
Principal Investigator: Norman B Schmidt, Ph.D.
Phone: 850-645-1766
Click here to add this to my saved trials
